AIGH Capital Management’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.07M Buy
1,128,343
+23,373
+2% +$92.7K 0.32% 31
2026
Q1
$4.08M Hold
1,104,970
0.56% 27
2025
Q4
$3.87M Buy
+1,104,970
New +$3.85M 0.94% 25
2024
Q1
Sell
-2,040,540
Closed -$5.35M 46
2023
Q4
$5.35M Buy
2,040,540
+145,309
+8% +$352K 2.12% 18
2023
Q3
$6.06M Buy
1,895,231
+628,432
+50% +$2.93M 2.87% 13
2023
Q2
$6.37M Buy
1,266,799
+742,798
+142% +$3.76M 2.6% 10
2023
Q1
$1.51M Buy
+524,001
New +$1.53M 0.56% 38

Other funds holding APYX

AIGH Capital Management's APYX Position: Q2 2026 in Review

AIGH Capital Management increased its Apyx Medical (APYX) stake by 2.1% in Q2 2026, buying an estimated $92.7K and bringing the position to 1,128,343 shares worth $5.07M. The position accounts for 0.32% of the portfolio, ranked #31.

AIGH Capital Management first reported a position in APYX in Q1 2023 and has held it in 7 quarters since. The position peaked at $6.37M in Q2 2023. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • AIGH Capital Management held 1,128,343 shares of Apyx Medical worth $5.07M as of Q2 2026.
  • AIGH Capital Management bought 23,373 Apyx Medical shares in Q2 2026, an estimated $92.7K.
  • Apyx Medical made up 0.32% of AIGH Capital Management's portfolio in Q2 2026, its #31 holding.
  • AIGH Capital Management first reported a position in Apyx Medical in Q1 2023 and has held it in 7 quarters since.
  • AIGH Capital Management's Apyx Medical position peaked at $6.37M in Q2 2023.
  • 68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on AIGH Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.